Do analysts recommend QTEX or OBIO?

Orchestra BioMed has a consensus price target of $13.60, suggesting a potential upside of 240.85%. Given Orchestra BioMed's stronger consensus rating and higher possible upside, analysts clearly believe Orchestra BioMed is more favorable than Inspira Technologies OXY B.H.N.. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inspira Technologies OXY B.H.N. 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Orchestra BioMed 1 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.57

Which has higher earnings & valuation, QTEX or OBIO?

Inspira Technologies OXY B.H.N. has higher earnings, but lower revenue than Orchestra BioMed. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Inspira Technologies OXY B.H.N. $290K 199.58 -$13.22M N/A N/A Orchestra BioMed $33.48M 7.14 -$52.70M -$0.97 N/A

Does the media refer more to QTEX or OBIO?

In the previous week, Inspira Technologies OXY B.H.N. and Inspira Technologies OXY B.H.N. both had 3 articles in the media. Inspira Technologies OXY B.H.N.'s average media sentiment score of 0.62 beat Orchestra BioMed's score of 0.44 indicating that Inspira Technologies OXY B.H.N. is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inspira Technologies OXY B.H.N. 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Orchestra BioMed 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend QTEX or RXST?

RxSight has a consensus price target of $8.89, suggesting a potential upside of 79.57%. Given RxSight's stronger consensus rating and higher probable upside, analysts clearly believe RxSight is more favorable than Inspira Technologies OXY B.H.N.. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inspira Technologies OXY B.H.N. 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 RxSight 3 Sell rating(s) 7 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.92

Which has stronger earnings and valuation, QTEX or RXST?

Inspira Technologies OXY B.H.N. has higher earnings, but lower revenue than RxSight. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Inspira Technologies OXY B.H.N. $290K 199.58 -$13.22M N/A N/A RxSight $134.48M 1.52 -$38.94M -$1.13 N/A

Does the media refer more to QTEX or RXST?

In the previous week, RxSight had 14 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 17 mentions for RxSight and 3 mentions for Inspira Technologies OXY B.H.N.. Inspira Technologies OXY B.H.N.'s average media sentiment score of 0.62 beat RxSight's score of 0.24 indicating that Inspira Technologies OXY B.H.N. is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inspira Technologies OXY B.H.N. 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive RxSight 2 Very Positive mention(s) 0 Positive mention(s) 10 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend QTEX or SMTI?

Sanara MedTech has a consensus target price of $34.00, indicating a potential upside of 42.74%. Given Sanara MedTech's stronger consensus rating and higher probable upside, analysts clearly believe Sanara MedTech is more favorable than Inspira Technologies OXY B.H.N.. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inspira Technologies OXY B.H.N. 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Sanara MedTech 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.60

Which has higher earnings and valuation, QTEX or SMTI?

Inspira Technologies OXY B.H.N. has higher earnings, but lower revenue than Sanara MedTech. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Inspira Technologies OXY B.H.N. $290K 199.58 -$13.22M N/A N/A Sanara MedTech $103.12M 2.12 -$37.56M -$3.77 N/A

Do analysts prefer QTEX or KRMD?

KORU Medical Systems has a consensus target price of $7.25, suggesting a potential upside of 69.39%. Given KORU Medical Systems' stronger consensus rating and higher probable upside, analysts plainly believe KORU Medical Systems is more favorable than Inspira Technologies OXY B.H.N.. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inspira Technologies OXY B.H.N. 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 KORU Medical Systems 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.60

Which has higher valuation & earnings, QTEX or KRMD?

KORU Medical Systems has higher revenue and earnings than Inspira Technologies OXY B.H.N.. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Inspira Technologies OXY B.H.N. $290K 199.58 -$13.22M N/A N/A KORU Medical Systems $41.13M 4.78 -$2.64M -$0.05 N/A

Does the media favor QTEX or KRMD?

In the previous week, Inspira Technologies OXY B.H.N. and Inspira Technologies OXY B.H.N. both had 3 articles in the media. Inspira Technologies OXY B.H.N.'s average media sentiment score of 0.62 beat KORU Medical Systems' score of 0.47 indicating that Inspira Technologies OXY B.H.N. is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inspira Technologies OXY B.H.N. 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive KORU Medical Systems 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend LUCD or QTEX?

Lucid Diagnostics currently has a consensus price target of $4.19, indicating a potential upside of 318.75%. Given Lucid Diagnostics' stronger consensus rating and higher probable upside, equities analysts clearly believe Lucid Diagnostics is more favorable than Inspira Technologies OXY B.H.N.. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lucid Diagnostics 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.60 Inspira Technologies OXY B.H.N. 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings & valuation, LUCD or QTEX?

Inspira Technologies OXY B.H.N. has lower revenue, but higher earnings than Lucid Diagnostics. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Lucid Diagnostics $4.71M 43.11 -$58.01M -$0.47 N/A Inspira Technologies OXY B.H.N. $290K 199.58 -$13.22M N/A N/A

Is LUCD or QTEX more profitable?

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to Lucid Diagnostics' net margin of -876.72%. Company Net Margins Return on Equity Return on Assets Lucid Diagnostics -876.72% N/A -116.26% Inspira Technologies OXY B.H.N. N/A N/A N/A

Inspira Technologies OXY B.H.N. (QTEX) Competitors

$1.61 +0.01 (+0.63%)

Closing price 07/10/2026 04:00 PM Eastern

Extended Trading

$1.58 -0.03 (-2.05%)

As of 07/10/2026 08:00 PM Eastern

Compare

QTEX vs. OBIO, RXST, SMTI, KRMD, and LUCD

Should you buy Inspira Technologies OXY B.H.N. stock or one of its competitors? MarketBeat compares Inspira Technologies OXY B.H.N. with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Inspira Technologies OXY B.H.N. include Orchestra BioMed (OBIO), RxSight (RXST), Sanara MedTech (SMTI), KORU Medical Systems (KRMD), and Lucid Diagnostics (LUCD). These companies are all part of the "medical equipment" industry.

How does Inspira Technologies OXY B.H.N. compare to Orchestra BioMed?

Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) and Orchestra BioMed (NASDAQ:OBIO) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, valuation, profitability, institutional ownership, risk, analyst recommendations, earnings and media sentiment.

Inspira Technologies OXY B.H.N. has a beta of 4.2, suggesting that its stock price is 320% more volatile than the broader market. Comparatively, Orchestra BioMed has a beta of 0.49, suggesting that its stock price is 51% less volatile than the broader market.

Inspira Technologies OXY B.H.N. has higher earnings, but lower revenue than Orchestra BioMed.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inspira Technologies OXY B.H.N.	$290K	199.58	-$13.22M	N/A	N/A
Orchestra BioMed	$33.48M	7.14	-$52.70M	-$0.97	N/A

In the previous week, Inspira Technologies OXY B.H.N. and Inspira Technologies OXY B.H.N. both had 3 articles in the media. Inspira Technologies OXY B.H.N.'s average media sentiment score of 0.62 beat Orchestra BioMed's score of 0.44 indicating that Inspira Technologies OXY B.H.N. is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Inspira Technologies OXY B.H.N.	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Orchestra BioMed	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to Orchestra BioMed's net margin of -166.96%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Orchestra BioMed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inspira Technologies OXY B.H.N.	N/A	N/A	N/A
Orchestra BioMed	-166.96%	-157.46%	-60.18%

Orchestra BioMed has a consensus price target of $13.60, suggesting a potential upside of 240.85%. Given Orchestra BioMed's stronger consensus rating and higher possible upside, analysts clearly believe Orchestra BioMed is more favorable than Inspira Technologies OXY B.H.N..

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inspira Technologies OXY B.H.N.	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Orchestra BioMed	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. Comparatively, 53.2% of Orchestra BioMed shares are held by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are held by insiders. Comparatively, 7.5% of Orchestra BioMed shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Inspira Technologies OXY B.H.N. beats Orchestra BioMed on 8 of the 13 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to RxSight?

Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) and RxSight (NASDAQ:RXST) are both small-cap medical equipment companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, dividends, analyst recommendations, valuation, earnings and media sentiment.

In the previous week, RxSight had 14 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 17 mentions for RxSight and 3 mentions for Inspira Technologies OXY B.H.N.. Inspira Technologies OXY B.H.N.'s average media sentiment score of 0.62 beat RxSight's score of 0.24 indicating that Inspira Technologies OXY B.H.N. is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Inspira Technologies OXY B.H.N.	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
RxSight	2 Very Positive mention(s)	0 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to RxSight's net margin of -36.58%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat RxSight's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inspira Technologies OXY B.H.N.	N/A	N/A	N/A
RxSight	-36.58%	-17.01%	-15.12%

Inspira Technologies OXY B.H.N. has higher earnings, but lower revenue than RxSight.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inspira Technologies OXY B.H.N.	$290K	199.58	-$13.22M	N/A	N/A
RxSight	$134.48M	1.52	-$38.94M	-$1.13	N/A

12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. Comparatively, 78.8% of RxSight shares are held by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are held by company insiders. Comparatively, 10.1% of RxSight shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

RxSight has a consensus price target of $8.89, suggesting a potential upside of 79.57%. Given RxSight's stronger consensus rating and higher probable upside, analysts clearly believe RxSight is more favorable than Inspira Technologies OXY B.H.N..

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inspira Technologies OXY B.H.N.	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
RxSight	3 Sell rating(s)	7 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.92

Inspira Technologies OXY B.H.N. has a beta of 4.2, meaning that its share price is 320% more volatile than the broader market. Comparatively, RxSight has a beta of 1.15, meaning that its share price is 15% more volatile than the broader market.

Summary

Inspira Technologies OXY B.H.N. beats RxSight on 8 of the 14 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to Sanara MedTech?

Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) and Sanara MedTech (NASDAQ:SMTI) are both small-cap medical equipment companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, institutional ownership, earnings, analyst recommendations, valuation and risk.

Inspira Technologies OXY B.H.N. has higher earnings, but lower revenue than Sanara MedTech.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inspira Technologies OXY B.H.N.	$290K	199.58	-$13.22M	N/A	N/A
Sanara MedTech	$103.12M	2.12	-$37.56M	-$3.77	N/A

Inspira Technologies OXY B.H.N. has a beta of 4.2, meaning that its stock price is 320% more volatile than the broader market. Comparatively, Sanara MedTech has a beta of 1.18, meaning that its stock price is 18% more volatile than the broader market.

12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. Comparatively, 8.1% of Sanara MedTech shares are owned by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are owned by company insiders. Comparatively, 42.0% of Sanara MedTech shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Sanara MedTech has a consensus target price of $34.00, indicating a potential upside of 42.74%. Given Sanara MedTech's stronger consensus rating and higher probable upside, analysts clearly believe Sanara MedTech is more favorable than Inspira Technologies OXY B.H.N..

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inspira Technologies OXY B.H.N.	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Sanara MedTech	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60

In the previous week, Inspira Technologies OXY B.H.N. had 2 more articles in the media than Sanara MedTech. MarketBeat recorded 3 mentions for Inspira Technologies OXY B.H.N. and 1 mentions for Sanara MedTech. Sanara MedTech's average media sentiment score of 0.94 beat Inspira Technologies OXY B.H.N.'s score of 0.62 indicating that Sanara MedTech is being referred to more favorably in the news media.

Company	Overall Sentiment
Inspira Technologies OXY B.H.N.	Positive
Sanara MedTech	Positive

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to Sanara MedTech's net margin of -31.23%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Sanara MedTech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inspira Technologies OXY B.H.N.	N/A	N/A	N/A
Sanara MedTech	-31.23%	-3.19%	-0.56%

Summary

Inspira Technologies OXY B.H.N. beats Sanara MedTech on 8 of the 15 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to KORU Medical Systems?

Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap medical equipment companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, media sentiment, dividends and valuation.

12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are owned by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are owned by insiders. Comparatively, 18.5% of KORU Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

KORU Medical Systems has higher revenue and earnings than Inspira Technologies OXY B.H.N..

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inspira Technologies OXY B.H.N.	$290K	199.58	-$13.22M	N/A	N/A
KORU Medical Systems	$41.13M	4.78	-$2.64M	-$0.05	N/A

KORU Medical Systems has a consensus target price of $7.25, suggesting a potential upside of 69.39%. Given KORU Medical Systems' stronger consensus rating and higher probable upside, analysts plainly believe KORU Medical Systems is more favorable than Inspira Technologies OXY B.H.N..

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inspira Technologies OXY B.H.N.	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

Inspira Technologies OXY B.H.N. has a beta of 4.2, suggesting that its stock price is 320% more volatile than the broader market. Comparatively, KORU Medical Systems has a beta of 0.41, suggesting that its stock price is 59% less volatile than the broader market.

In the previous week, Inspira Technologies OXY B.H.N. and Inspira Technologies OXY B.H.N. both had 3 articles in the media. Inspira Technologies OXY B.H.N.'s average media sentiment score of 0.62 beat KORU Medical Systems' score of 0.47 indicating that Inspira Technologies OXY B.H.N. is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Inspira Technologies OXY B.H.N.	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
KORU Medical Systems	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to KORU Medical Systems' net margin of -5.27%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat KORU Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inspira Technologies OXY B.H.N.	N/A	N/A	N/A
KORU Medical Systems	-5.27%	-13.61%	-8.33%

Summary

Inspira Technologies OXY B.H.N. beats KORU Medical Systems on 7 of the 13 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to Lucid Diagnostics?

Lucid Diagnostics (NASDAQ:LUCD) and Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) are both small-cap medical equipment companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, dividends, profitability, valuation, analyst recommendations, institutional ownership and media sentiment.

Inspira Technologies OXY B.H.N. has lower revenue, but higher earnings than Lucid Diagnostics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lucid Diagnostics	$4.71M	43.11	-$58.01M	-$0.47	N/A
Inspira Technologies OXY B.H.N.	$290K	199.58	-$13.22M	N/A	N/A

Lucid Diagnostics currently has a consensus price target of $4.19, indicating a potential upside of 318.75%. Given Lucid Diagnostics' stronger consensus rating and higher probable upside, equities analysts clearly believe Lucid Diagnostics is more favorable than Inspira Technologies OXY B.H.N..

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lucid Diagnostics	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Inspira Technologies OXY B.H.N.	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Inspira Technologies OXY B.H.N. had 2 more articles in the media than Lucid Diagnostics. MarketBeat recorded 3 mentions for Inspira Technologies OXY B.H.N. and 1 mentions for Lucid Diagnostics. Lucid Diagnostics' average media sentiment score of 0.93 beat Inspira Technologies OXY B.H.N.'s score of 0.62 indicating that Lucid Diagnostics is being referred to more favorably in the media.

Company	Overall Sentiment
Lucid Diagnostics	Positive
Inspira Technologies OXY B.H.N.	Positive

Lucid Diagnostics has a beta of 1.07, indicating that its stock price is 7% more volatile than the broader market. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 4.2, indicating that its stock price is 320% more volatile than the broader market.

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to Lucid Diagnostics' net margin of -876.72%.

Company	Net Margins	Return on Equity	Return on Assets
Lucid Diagnostics	-876.72%	N/A	-116.26%
Inspira Technologies OXY B.H.N.	N/A	N/A	N/A

74.0% of Lucid Diagnostics shares are owned by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. 6.9% of Lucid Diagnostics shares are owned by company insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Inspira Technologies OXY B.H.N. beats Lucid Diagnostics on 7 of the 13 factors compared between the two stocks.

Get Inspira Technologies OXY B.H.N. News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QTEX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

QTEX vs. The Competition

Export

Metric	Inspira Technologies OXY B.H.N.	Surgical, Medical, And Dental Instruments And Supplies Industry	Manufacturing Sector	NASDAQ Exchange
Market Cap	$57.88M	$3.25B	$5.11B	$12.66B
Dividend Yield	N/A	N/A	27.49%	8.00%
P/E Ratio	N/A	22.46	23.85	24.53
Price / Sales	199.58	298.91	154.14	96.17
Price / Cash	N/A	9.27	165.86	60.03
Price / Book	26.83	6.13	13.02	6.38
Net Income	-$13.22M	$23.43M	$116.30M	$331.87M
7 Day Performance	12.59%	0.28%	-1.03%	0.37%
1 Month Performance	24.81%	-2.03%	-0.64%	0.59%
1 Year Performance	N/A	-39.94%	9.98%	22.26%

Inspira Technologies OXY B.H.N. Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
QTEX Inspira Technologies OXY B.H.N.	0.4859 of 5 stars	$1.61 +0.6%	N/A	N/A	$57.88M	$290K	N/A	20	News Coverage
OBIO Orchestra BioMed	4.2474 of 5 stars	$3.92 -1.0%	$13.60 +246.9%	+36.6%	$237.13M	$33.48M	N/A	4	News Coverage Short Interest Increase
RXST RxSight	2.8647 of 5 stars	$5.34 -5.0%	$8.89 +66.5%	-38.1%	$232.65M	$134.48M	N/A	220	News Coverage Analyst Forecast
SMTI Sanara MedTech	2.1525 of 5 stars	$24.23 -2.3%	$34.00 +40.3%	-18.0%	$227.18M	$103.12M	N/A	60
KRMD KORU Medical Systems	4.2632 of 5 stars	$4.43 -3.5%	$7.25 +63.7%	+23.0%	$210.83M	$41.13M	N/A	80	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:QTEX) was last updated on 7/12/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Inspira Technologies OXY B.H.N. (QTEX) Competitors

QTEX vs. OBIO, RXST, SMTI, KRMD, and LUCD

How does Inspira Technologies OXY B.H.N. compare to Orchestra BioMed?

Summary

How does Inspira Technologies OXY B.H.N. compare to RxSight?

Summary

How does Inspira Technologies OXY B.H.N. compare to Sanara MedTech?

Summary

How does Inspira Technologies OXY B.H.N. compare to KORU Medical Systems?

Summary

How does Inspira Technologies OXY B.H.N. compare to Lucid Diagnostics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

QTEX vs. The Competition

Inspira Technologies OXY B.H.N. Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Inspira Technologies OXY B.H.N. (QTEX) Competitors

QTEX vs. OBIO, RXST, SMTI, KRMD, and LUCD

How does Inspira Technologies OXY B.H.N. compare to Orchestra BioMed?

Which has more risk & volatility, QTEX or OBIO?

Which has higher earnings & valuation, QTEX or OBIO?

Does the media refer more to QTEX or OBIO?

Is QTEX or OBIO more profitable?

Do analysts recommend QTEX or OBIO?

Do insiders & institutionals have more ownership in QTEX or OBIO?

Summary

How does Inspira Technologies OXY B.H.N. compare to RxSight?

Does the media refer more to QTEX or RXST?

Is QTEX or RXST more profitable?

Which has stronger earnings and valuation, QTEX or RXST?

Do insiders & institutionals have more ownership in QTEX or RXST?

Do analysts recommend QTEX or RXST?

Which has more volatility and risk, QTEX or RXST?

Summary

How does Inspira Technologies OXY B.H.N. compare to Sanara MedTech?

Which has higher earnings and valuation, QTEX or SMTI?

Which has more volatility & risk, QTEX or SMTI?

Do insiders and institutionals believe in QTEX or SMTI?

Do analysts recommend QTEX or SMTI?

Does the media refer more to QTEX or SMTI?

Is QTEX or SMTI more profitable?

Summary

How does Inspira Technologies OXY B.H.N. compare to KORU Medical Systems?

Do institutionals and insiders have more ownership in QTEX or KRMD?

Which has higher valuation & earnings, QTEX or KRMD?

Do analysts prefer QTEX or KRMD?

Which has more risk & volatility, QTEX or KRMD?

Does the media favor QTEX or KRMD?

Is QTEX or KRMD more profitable?

Summary

How does Inspira Technologies OXY B.H.N. compare to Lucid Diagnostics?

Which has better earnings & valuation, LUCD or QTEX?

Do analysts recommend LUCD or QTEX?

Does the media prefer LUCD or QTEX?

Which has more volatility & risk, LUCD or QTEX?

Is LUCD or QTEX more profitable?

Do insiders & institutionals believe in LUCD or QTEX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

QTEX vs. The Competition

Inspira Technologies OXY B.H.N. Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools